Cargando…

A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett’s Esophagus

PURPOSE: This study evaluates the cost-effectiveness of a quantitative multi-biomarker assay (the Assay) that stratifies patients with Barrett’s Esophagus (BE) by risk of progression to high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC) and can be used to guide clinical decisions, versus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Jing, Critchley-Thorne, Rebecca, Diehl, David L, Snyder, Susan R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818671/ https://www.ncbi.nlm.nih.gov/pubmed/31749626 http://dx.doi.org/10.2147/CEOR.S221741

Ejemplares similares

TissueCypher Barrett’s esophagus assay impacts clinical decisions in the management of patients with Barrett’s esophagus
por: Diehl, David L., et al.
Publicado: (2021)

Identification of potential biomarkers in Barrett’s esophagus derived esophageal adenocarcinoma
por: Yi, Nan, et al.
Publicado: (2023)

Adenocarcinoma of Barrett’s esophagus in a dog
por: Chambers, James K., et al.
Publicado: (2017)

Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021)

Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis
por: Frei, Nicola F., et al.
Publicado: (2020)

Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2020)

Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett’s esophagus
por: Lv, Jing, et al.
Publicado: (2019)

Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014)

Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy
por: Wolfsen, Herbert C, et al.
Publicado: (2004)

Paired Exome Analysis of Barrett’s Esophagus and Adenocarcinoma
por: Stachler, Matthew D., et al.
Publicado: (2015)

Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma
por: Huhta, Heikki, et al.
Publicado: (2017)

Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2019)

A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus
por: Davison, Jon M., et al.
Publicado: (2023)

Differences in the Characteristics of Barrett's Esophagus and Barrett's Adenocarcinoma between the United States and Japan
por: Oryu, Makoto, et al.
Publicado: (2013)

Barrett's esophagus : columnar lined esophagus
Publicado: (2003)

Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007)

Multicentric Adenocarcinomas in a Long-Segment of Barrett’s Esophagus
por: Hartl, Stefan, et al.
Publicado: (2008)

Progression of Barrett’s esophagus toward esophageal adenocarcinoma: an overview
por: Schoofs, Nele, et al.
Publicado: (2017)

Advances in the management of Barrett’s esophagus and early esophageal adenocarcinoma
por: Singh, Ajaypal, et al.
Publicado: (2015)

Signaling Pathways in the Pathogenesis of Barrett’s Esophagus and Esophageal Adenocarcinoma
por: Maslenkina, Ksenia, et al.
Publicado: (2023)

Epigenetic Alterations from Barrett’s Esophagus to Esophageal Adenocarcinoma
por: Ergun, Pelin, et al.
Publicado: (2023)

Clinical variation in surveillance and management of Barrett’s esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons
por: Cruz, Jamielyn DC, et al.
Publicado: (2022)

Risk Factors for Progression of Barrett’s Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma
por: Kambhampati, Swetha, et al.
Publicado: (2020)

Barrett’s esophagus: an exaggerated risk?
por: Bisschops, Raf
Publicado: (2012)

Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening
por: Yang, Yu, et al.
Publicado: (2015)

Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening
por: Yang, Yu, et al.
Publicado: (2015)

Surveillance in Barrett Esophagus
por: Gindea, C, et al.
Publicado: (2014)

The treatment of Barrett’s esophagus
por: Hoara, Petre, et al.
Publicado: (2009)

Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma
por: Wennerström, E. Christina M., et al.
Publicado: (2016)

Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma
por: Smith, Eric, et al.
Publicado: (2008)

Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas
por: Sun, Xiangqing, et al.
Publicado: (2016)

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Differences in Gut Virome Related to Barrett Esophagus and Esophageal Adenocarcinoma
por: Ma, Tianli, et al.
Publicado: (2021)

Genetic profiles of Barrett’s esophagus and esophageal adenocarcinoma in Japanese patients
por: Tokunaga, Mamoru, et al.
Publicado: (2021)

Artificial Intelligence in the Management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma
por: Dumoulin, Franz Ludwig, et al.
Publicado: (2022)

Clonal cell states link Barrett’s esophagus and esophageal adenocarcinoma
por: Gier, Rodrigo A., et al.
Publicado: (2023)

Increased Oxidative Stress in the Proximal Stomach of Patients with Barrett’s Esophagus and Adenocarcinoma of the Esophagus and Esophagogastric Junction()
por: Kauppi, Juha, et al.
Publicado: (2016)

The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus
por: Eluri, Swathi, et al.
Publicado: (2015)

Healthcare Resource Utilization and Costs Among Patients With Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Barrett’s Esophagus-Related Neoplasia in the United States
por: Sharma, Prateek, et al.
Publicado: (2023)

Screening for Barrett’s Esophagus: Balancing Clinical Value and Cost-effectiveness
por: Patel, Amit, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5tlfumhcm615fh5ou4q0ujm20f